No need to travel to the pharmacy
(2019) 2019:190087:EDM190087
Reasons for rejection include: Substantial equivalence not proved Inadequate documentation (missing elements from the FDA 510(k) Submission Checklist) Submission incorrectly formatted Inadequate testing data Absent Risk Management data Inaccurate Device Descriptions Discrepancies in indications of use No records of validation testing Its crucial that your submission clearly demonstrates your devices safety and effectiveness, with robust validation testing and risk management data
It has been shown to enhance mitochondrial membrane potential, enhance the efficiency of oxidative phosphorylation and inhibit the release of pro-apoptotic factors
As an example, in experimental conditions with animal models (GLP-1R-null), TZP reduced appetite and food intake, liver glycogenolysis and gluconeogenesis, improved insulin sensibility (assessed by euglycemic clamp) and glucose disposal in white and brown adipose tissue, skeletal muscle, with body weight-dependent and independent effects (73)
It causes sagging skin and leads to more skin problems
